MENU
RLYB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rallybio (RLYB) Ownership - Who owns Rallybio?

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

Profile

Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.92M
P/E Ratio
N/A
Total Cash
59.32M
Projected Growth
N/A
Total Debt
198K
Revenue
674K
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
1.40
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price

Fundamentals

RLYB
Capitalization
30.9M
P/E Ratio
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
59.3M
Total Cash/Share
1.40
Total Debt
198K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
674K
ROE
N/A
Book Value
63M
P/B Ratio
0.49
Cash Flow
N/A
Earnings
-0.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
14.74
Current Revenue Per Employee
14133.33
Dividends Per Share - Security
N/A
EBITDA
-38.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.32
Shares Held By Institutions
15.3M
Shares Outstanding - Current
42.2M
Total Liabilities
4.63M
Total Volume MTD
N/A
Value
1
Gain YTD
-22.760
View a ticker or compare two or three
RLYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com